J&J's Drug Sales Help Health Giant Beat Earnings Estimates

  • Company raises 2016 forecast, citing foreign exchange rates
  • Sales of medical devices, consumer products both decline

J&J CFO Caruso Breaks Down the Earnings Numbers

Johnson & Johnson reported earnings that beat analysts’ estimates on strong sales of pharmaceuticals, the company’s biggest division.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.